Effect of Covishield vaccine in CKD patients versus healthy individuals
- Conditions
- Health Condition 1: N189- Chronic kidney disease, unspecified
- Registration Number
- CTRI/2022/10/046209
- Lead Sponsor
- JIPMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Apparently healthy population with no underlying diseases with age � 18 years.
2. Vaccinated or have intent to vaccinate with Cov-ishield according to standard protocol.
1.Age � 18 years with Chronic Kidney disease not on dialysis
2. Vaccinated or have intent to vaccinate with Cov-ishield according to standard protocol.
1. Chronic kidney disease patients who are recipi-ents of kidney transplant
2. Chronic kidney disease patients with chronic use or high dose steroids or immunosuppresants during the study period.
3. Previous known Covid 19 illness.
4. People with cocommitant co-morbidities such as autoimmune diseases, liver cirrhosis,Congestive heart failure, cancer and HIV.
5. Partially vaccinated individuals.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the immunogenicity of Covishield vac-cine in Non-Dialysis Chronic Kidney Disease pa-tients with healthy subjects by measuring the IgG levels against spike protein in response to Covishield vaccineTimepoint: between 21 to 28 days post vaccination, <br/ ><br>3 months
- Secondary Outcome Measures
Name Time Method